Alcami Capabilities Update October 2026: Fill Finish

Bringing a sterile drug product from development to the patient requires more than filling capacity. Success depends on the coordinated management of technology transfer, process development, formulation, aseptic manufacturing, analytical testing and packaging; all of which include quality oversight—each aligned to protect product integrity and support regulatory compliance.

This session will explore the critical considerations across the sterile fill-finish lifecycle, including early manufacturability assessment, process scale-up, contamination-control strategies and the transition from clinical to commercial supply. It will also examine how integrated expertise, robust quality systems and effective collaboration can help sponsors reduce handoff risks, maintain program continuity and respond to evolving product requirements.

Attendees will gain practical insight into selecting and working with a CDMO capable of supporting complex sterile products from drug product development through fill-finish, packaging and delivery to patients.